News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Clinical Protocol for Evaluating Pharmacogenomic Variants for Cardiology Therapeutics

Study Status:

Closed for enrollment

Contact Information:

(956) 362-8046

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of this study is to enhance the understanding of the impact of genetic variants on individuals of Hispanic/Latino ancestry, especially as the variants pertain to the efficacy and safety of medications. The patient specimen is genotyped using a proprietary, carefully curated pharmacogenetic variant panel to determine the individual's phenotype. The Lighthouse report (PGx findings) are provided to the clinician, and a notification is generated when the patient has a genotype with a deleterious drug-metabolizing phenotype.

Information: 

Principal Investigator
Herschl B. Silberman, MD
Co-PI
Victoria Mancillas
Sponsor
Cipherome
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram